Accelrys Receives Non-Compliance Notice from Nasdaq…

Accelrys said last week that it had received a notice from Nasdaq stating that it is not in compliance with Nasdaq's Marketplace Rule 4310(c)(14) because it has not filed its quarterly report for its fiscal quarter ended Dec. 31, 2005.

Accelrys warned earlier this month that it would not file its quarterly report in time because it is in the process of restating its financial statements from Jan. 1, 2000, to Sept. 30, 2005, and that it expected to receive such a letter [BioInform 2-10-06].

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.